Marisa Iborra

573 total citations
23 papers, 282 citations indexed

About

Marisa Iborra is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Marisa Iborra has authored 23 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Marisa Iborra's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (9 papers) and Acute Lymphoblastic Leukemia research (4 papers). Marisa Iborra is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (9 papers) and Acute Lymphoblastic Leukemia research (4 papers). Marisa Iborra collaborates with scholars based in Spain and United States. Marisa Iborra's co-authors include Eva Sesé, José Castellote, Antonia Perelló, Xavier Xiol, Josep M. Simón Castellví, Jordi Guardiola, Pilar Nos, Belén Beltrán, Guillermo Bastida and Vicente Garrigues and has published in prestigious journals such as Gastroenterology, Hepatology and Scientific Reports.

In The Last Decade

Marisa Iborra

21 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marisa Iborra Spain 8 127 112 91 78 67 23 282
Veerle Moons Belgium 8 149 1.2× 68 0.6× 150 1.6× 92 1.2× 20 0.3× 22 337
Cilénia Baldaia Portugal 10 316 2.5× 135 1.2× 148 1.6× 241 3.1× 25 0.4× 25 455
Jason Eccleston United States 6 200 1.6× 152 1.4× 82 0.9× 50 0.6× 54 0.8× 13 359
A. Elewaut Belgium 11 239 1.9× 186 1.7× 153 1.7× 98 1.3× 32 0.5× 38 504
Yana Davidov Israel 7 200 1.6× 115 1.0× 101 1.1× 104 1.3× 77 1.1× 28 380
Cristina Cijevschi Prelipcean Romania 10 103 0.8× 44 0.4× 88 1.0× 103 1.3× 15 0.2× 59 279
Gil Ben Yakov United States 11 129 1.0× 85 0.8× 44 0.5× 33 0.4× 111 1.7× 30 311
Arnaud Boruchowicz France 10 160 1.3× 45 0.4× 239 2.6× 139 1.8× 20 0.3× 34 422
N. Maàmouri Tunisia 9 164 1.3× 155 1.4× 59 0.6× 17 0.2× 47 0.7× 65 307
Laura Walters United States 7 119 0.9× 69 0.6× 33 0.4× 15 0.2× 74 1.1× 16 304

Countries citing papers authored by Marisa Iborra

Since Specialization
Citations

This map shows the geographic impact of Marisa Iborra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Iborra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Iborra more than expected).

Fields of papers citing papers by Marisa Iborra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Iborra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Iborra. The network helps show where Marisa Iborra may publish in the future.

Co-authorship network of co-authors of Marisa Iborra

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Iborra. A scholar is included among the top collaborators of Marisa Iborra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Iborra. Marisa Iborra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garrido, António, et al.. (2025). P0937 Role of Interleukin-8 in Predicting Long-Term Response to Vedolizumab in Ulcerative Colitis Patients. Journal of Crohn s and Colitis. 19(Supplement_1). i1758–i1758.
2.
Coello, Eduardo, Alícia Garrido, Marisa Iborra, et al.. (2024). Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real world. Gastroenterología y Hepatología. 48(5). 502253–502253.
3.
Bastida, Guillermo, et al.. (2023). Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine. Gastroenterología y Hepatología. 47(5). 473–480. 1 indexed citations
4.
Martínez‐Blanch, Juan F., et al.. (2021). Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment. Scientific Reports. 11(1). 10016–10016. 30 indexed citations
5.
Sáez‐González, Esteban, Inés Moret, David Hervás, et al.. (2020). Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn’s Disease Response to Infliximab, as Assessed by Calprotectin Log Drop. Digestive Diseases. 39(1). 1–9. 9 indexed citations
6.
Fernández-Clotet, A, Alejandro Hernández-Camba, Marisa Iborra, et al.. (2020). P462 Efficacy of ustekinumab for the prevention of postoperative recurrence in crohn’s disease. Data from clinical practice from the eneida registry. Journal of Crohn s and Colitis. 14(Supplement_1). S410–S410. 3 indexed citations
7.
Iborra, Marisa, et al.. (2020). Enfermedad de Whipple. Medicine - Programa de Formación Médica Continuada Acreditado. 13(11). 613–617. 1 indexed citations
8.
Navarro, Belén, et al.. (2018). Infarto agudo de miocardio en paciente con diagnóstico reciente de enfermedad de Crohn. Gastroenterología y Hepatología. 42(3). 183–184. 1 indexed citations
9.
Iborra, Marisa, Inés Moret, Elena Cerrillo, et al.. (2018). Different Genetic Expression Profiles of Oxidative Stress and Apoptosis-Related Genes in Crohn’s Disease. Digestion. 100(1). 27–36. 5 indexed citations
10.
Iborra, Marisa, et al.. (2018). Tuberculosis intestinal, simulador de la enfermedad de Crohn: diagnóstico diferencial. Gastroenterología y Hepatología. 42(1). 29–32. 1 indexed citations
11.
Beltrán, Belén, Esteban Sáez‐González, Inés Moret, et al.. (2017). Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines. Journal of Clinical Apheresis. 33(1). 99–103. 2 indexed citations
12.
Ortiz, Vicente, et al.. (2017). Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?. Gut and Liver. 11(3). 358–362. 10 indexed citations
13.
Iborra, Marisa, Belén Navarro, Xavier Cortés, et al.. (2016). P459. Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remission. Journal of Crohn s and Colitis. 10(suppl 1). S333–S334. 1 indexed citations
14.
Hernández‐Breijo, Borja, María Chaparro, Iván Guerra, et al.. (2016). Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn’s disease patients treated with infliximab. Biochemical Pharmacology. 122. 33–41. 10 indexed citations
15.
Bastida, Guillermo, Miguel Á. Arnau, Marisa Iborra, et al.. (2012). Tromboembolia arterial periférica en enfermedad de Crohn. Gastroenterología y Hepatología. 36(1). 30–34. 2 indexed citations
16.
Aguas, Mariam, Guillermo Bastida, Elena Cerrillo, et al.. (2012). Sa2029 Impact of Adalimumab in the Prevention of Postoperative Recurrences of Crohn's Disease in High-Risk Patients. Gastroenterology. 142(5). S–384. 1 indexed citations
17.
Bastida, Guillermo, Pilar Nos, Mariam Aguas, et al.. (2010). The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients. BMC Gastroenterology. 10(1). 26–26. 19 indexed citations
18.
Iborra, Marisa, Pilar Nos, J L Rueda García, et al.. (2009). P298 - Permanent catalase activity impairment due to minor expression of catalase protein in peripheral white mononuclear cells of patients with naive and treated Crohn's disease. Journal of Crohn s and Colitis. 3(1). S128–S128. 1 indexed citations
19.
Xiol, Xavier, Josep M. Simón Castellví, Jordi Guardiola, et al.. (1996). Spontaneous bacterial empyema in cirrhotic patients: A prospective study. Hepatology. 23(4). 719–723. 138 indexed citations
20.
Baliellas, Carme, Eva Sesé, Marisa Iborra, et al.. (1995). Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant.. PubMed. 27(4). 2229–30. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veerle Moons Breakdown of academic impact, for papers by Cilénia Baldaia Breakdown of academic impact, for papers by Jason Eccleston Breakdown of academic impact, for papers by A. Elewaut Breakdown of academic impact, for papers by Yana Davidov Breakdown of academic impact, for papers by Cristina Cijevschi Prelipcean Breakdown of academic impact, for papers by Gil Ben Yakov Breakdown of academic impact, for papers by Arnaud Boruchowicz Breakdown of academic impact, for papers by N. Maàmouri Breakdown of academic impact, for papers by Laura Walters
Rankless by CCL
2026